Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#2282 Value of Somatostatin Receptor Scintigraphy (SRS) in Patients with Appendiceal Neuroendocrine Neoplasms (ANEN) Based on Clinical Follow-up and Results of NETest

Introduction: Neuroendocrine neoplasms of the appendix (ANEN) are one of the most commonly identified gastroentropancreatic tumours (GEP). The aim of this retrospective study was to review the value of Somatostatin Receptor Scintigraphy (SRS) in staging and imaging follow-up of patients with confirmed ANEN, NENG1 and NENG2 in single institution.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Konsek S, Kolasińska-Ćwikła A, Lewczuk-Myślińska A, Kidd M, Buscombe J,

Keywords: appendiceal neuroendocrine neoplasm, ANEN, somatostatin receptor scintigraphy, SRS, NETest,

#2010 A case of Carcinoid Crisis Despite High Dose Somatostatin Analogue Therapy Peri-operatively

Introduction: Carcinoid crisis is a life threatening endocrine emergency. Somatostatin analogues (SSA) are recommended as prophylactic administration before invasive procedures. It remains unclear whether there is an optimal dose of prophylactic somatostatin analogue therapy in the peri-operative period.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Pitfield D, Casey R, Seetho I, Shaw A, Buscombe J,

Keywords: carcinoid syndrome, carcinoid crisis, octreotide, surgery,

#124 Management and outcomes of malignant paragangliomas and phaeochromocytomas

Introduction: Chromaffin-cell tumors include phaeochromocytomas and paragangliomas, represent a rare group of neuroendocrine tumors and are located in adrenal medulla or extra-adrenal sites, respectively. Ten percent of phaeochromocytomas and 15-35% of paragangliomas are malignant.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author: TOUMPANAKIS C

Authors: Warner B, Chilkunda D, Khan M, Buscombe J, Caplin M,

Keywords: paragangliomas, phaeochromocytomas, chromaffin-cell tumours,